首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555) a new oral penem compared with those to penicillin G amoxicillin amoxicillin-clavulanate cefixime cefaclor cefpodoxime cefuroxime and cefdinir.
【2h】

In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555) a new oral penem compared with those to penicillin G amoxicillin amoxicillin-clavulanate cefixime cefaclor cefpodoxime cefuroxime and cefdinir.

机译:与新的口服青霉素WY-49605(SUN / SY 5555)相比185种对青霉素敏感和耐药的肺炎球菌的体外敏感性与对青霉素G阿莫西林阿莫西林-克拉维酸头孢克肟头孢克洛头孢泊肟头孢呋肟头孢呋辛肟的比较头孢地尼。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In vitro susceptibility of 185 penicillin-susceptible and -resistant pneumococci to WY-49605, a new oral penem, was compared with susceptibility to penicillin G, amoxicillin with and without clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. WY-49605 yielded MICs for 50 and 90% of the strains tested (MIC50 and MIC90, respectively) of 0.03 and 0.06, 0.125 and 0.5, and 0.5 and 1.0 micrograms/ml, respectively, against penicillin-susceptible, intermediately resistant, and fully resistant strains, respectively. The MIC50 and MIC90 for both amoxicillin and amoxicillin-clavulanate were identical and approximately 1 doubling dilution higher than those for WY-49605 and were < or = 0.06 and 0.125, 0.25 and 1.0, and 1.0 and 1.0 micrograms/ml, respectively. Cephalosporin MIC90s were all significantly higher than those of the latter three compounds for intermediately resistant and fully resistant strains.
机译:将185种对青霉素敏感和耐药的肺炎球菌对新型口服青霉素WY-49605的体外敏感性与对青霉素G,阿莫西林(含或不含克拉维酸盐),头孢克肟,头孢克洛,头孢泊肟,头孢呋辛和头孢地尼的敏感性进行了比较。 WY-49605对青霉素易感,中等耐药和完全耐药的菌株分别产生了0.03和0.06、0.125和0.5、0.5和1.0和1.0微克/毫升的50%和90%的MIC(分别为MIC50和MIC90)抗性菌株。阿莫西林和阿莫西林-克拉维酸的MIC50和MIC90相同,并且比WY-49605的MIC50和MIC90高约1倍,分别≤0.06和0.125、0.25和1.0、1.0和1.0微克/毫升。对于中抗性和完全抗性菌株,头孢菌素MIC90均显着高于后三种化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号